A -year-old man with a history of type diabetes mellitus is brought to the emergency department due to altered mental status, nausea, and vomiting for the past hours. He recently had an upper respiratory tract infection. Vital signs are temperature (), blood pressure , pulse , and respirations with deep, rapid breaths. Laboratory studies show a serum glucose of , arterial pH of , serum bicarbonate of , and an anion gap of . Urine is strongly positive for ketones. Arrange the following interventions in the most appropriate chronological order for the acute management of this patient.
- 1Administer a bolus of intravenous normal saline
- 2Verify that the serum potassium level is greater than
- 3Initiate a continuous intravenous regular insulin infusion
- 4Add dextrose to the maintenance intravenous fluids when serum glucose reaches
- 5Transition to a subcutaneous insulin regimen and overlap with the intravenous infusion
Answer
The correct chronological sequence for Diabetic Ketoacidosis management is: 1) Administer intravenous normal saline, 2) Verify serum potassium levels, 3) Initiate intravenous regular insulin, 4) Add 5% dextrose when glucose drops below 200 mg/dL, and 5) Transition to subcutaneous insulin when the anion gap closes.
Optimal management of Diabetic Ketoacidosis follows a strict evidence-based sequence. Initial rapid fluid resuscitation with normal saline restores intravascular volume and renal perfusion. Next, potassium must be assessed (and replaced if necessary) before starting insulin to avoid life-threatening hypokalemia. Only after confirming a safe potassium level () is an intravenous insulin drip started to correct the ketoacidosis. As glucose levels predictably fall below , dextrose is added to the fluids to prevent hypoglycemia while allowing continued insulin administration to successfully close the anion gap. Finally, once the anion gap normalizes and the patient can eat, they are safely transitioned to a subcutaneous insulin regimen.
Step-by-Step Solution
Key Concept
The stepwise management of Diabetic Ketoacidosis (DKA)